Table 2 Clinical characteristics of the cocaine and alcohol groups.

Primary substance use disorder in treatment [n (%)]

AUD

28 (100.0)

–

–

CUD

–

28 (100.0)

Comorbid substance use disorders (AUD) [n (%)]

Yes

0 (0.0)

14 (50.0)

< 0.001^a

No

28 (100.0)

14 (50.0)

Comorbid mental disorders [n (%)]

Yes

16 (57.1)

22 (78.6)

0.152^a

No

12 (42.9)

6 (21.4)

Mood disorders

12 (42.9)

22 (78.6)

0.013^a

Anxiety disorders

8 (28.6)

12 (42.9)

0.403^a

Psychotic disorders

0 (0.0)

6 (21.4)

0.023^a

Eating disorders

2 (7.1)

0 (0.0)

0.491^a

Personality disorders

0 (0.0)

6 (21.4)

0.023^a

Cocaine abstinence (day)

Median (IQR)

0.0 (0.0–0.0)

25.5 (15.0–38.0)

–

Alcohol abstinence (day)

Median (IQR)

60.0 (27.0–98.0)

25.5 (7.0–38.0)

0.004^b

Smoking [n (%)]

Yes

18 (64.3)

20 (71.4)

0.286^a

No

4 (14.3)

6 (21.4)

Ex-smoker

6 (21.4)

2 (7.1)

Obesity [n (%)]

BMI (≥ 30)

12 (42.9)

11 (39.3)

0.999^a

Type 2 diabetes mellitus [n (%)]

Yes

7 (25.0)

5 (17.9)

0.746^a

No

21 (75.0)

23 (82.1)

Hypertension and cardiovascular conditions [n (%)]

Yes

18 (64.3)

12 (42.9)

0.180^a

No

10 (35.7)

16 (57.1)

Hypertension

14 (50.0)

8 (28.6)

0.171^a

Arrhythmia

6 (21.4)

6 (21.4)

0.999^a

Atherosclerosis

5 (17.9)

6 (21.4)

0.999^a

Coronary artery disease

0 (0.0)

1 (3.6)

0.999^a